Cargando…
Peptides for diagnosis and treatment of ovarian cancer
Ovarian cancer is the most deadly gynecologic malignancy, and its incidence is gradually increasing. Despite improvements after treatment, the results are unsatisfactory and survival rates are relatively low. Therefore, early diagnosis and effective treatment remain two major challenges. Peptides ha...
Autores principales: | Guo, Ling, Wang, Jing, Li, Nana, Cui, Jialin, Su, Yajuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196167/ https://www.ncbi.nlm.nih.gov/pubmed/37213272 http://dx.doi.org/10.3389/fonc.2023.1135523 |
Ejemplares similares
-
Purified Vitexin Compound 1 Serves as a Promising Antineoplastic Agent in Ovarian Cancer
por: Ma, Kewen, et al.
Publicado: (2021) -
Advances in the Application of Radionuclide-Labeled HER2 Affibody for the Diagnosis and Treatment of Ovarian Cancer
por: Hu, Xianwen, et al.
Publicado: (2022) -
Ferroptosis in Ovarian Cancer: A Novel Therapeutic Strategy
por: Li, Lanyu, et al.
Publicado: (2021) -
Can Circulating Cell-Free DNA or Circulating Tumor DNA Be a Promising Marker in Ovarian Cancer?
por: Yu, Ming, et al.
Publicado: (2021) -
Gonadotropin-releasing hormone agonist protects ovarian function in young patients with ovarian malignancy undergoing platinum-based chemotherapy: A prospective study
por: Xie, Ya, et al.
Publicado: (2022)